We are live on ! Find out more
SR

Summer Road Portfolio holdings

AUM $161M
1-Year Est. Return 27.24%
This Fund
S&P 500
This Quarter Est. Return
+68.28%
1 Year Est. Return
+27.24%
3 Year Est. Return
+129.62%
5 Year Est. Return
-16.44%
10 Year Est. Return
+274.48%
AUM
$46.8M
AUM Growth
+$20.7M
Cap. Flow
+$2.31M
Cap. Flow %
4.94%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
1
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
OCUL icon
Ocular Therapeutix
OCUL
+$2.41M

Top Sells

Rank Stock Value
1
CORV
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
+$97K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCUL icon
1
Ocular Therapeutix
OCUL
$2.58B
$46.8M 100%
5,618,424
+363,636
+7% +$2.41M
CORV
2
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
– –
-250,000
Closed -$97K

Similar funds

SFCM
Savoir Faire Capital Management Norwalk, Connecticut $161M AUM 3.8% 1-Year Est. Return
LWM
Lighthouse Wealth Management Ashland, Ohio $161M AUM 19.46% 1-Year Est. Return
MWM
Mascagni Wealth Management Clinton, Mississippi $161M AUM 26.58% 1-Year Est. Return
MCM
MidAtlantic Capital Management Richmond, Virginia $161M AUM 18.73% 1-Year Est. Return
BFS
Burr Financial Services Pleasant Hill, California $161M AUM 80.86% 1-Year Est. Return
MMCM
Murphy & Mullick Capital Management Smithtown, New York $161M AUM 39.43% 1-Year Est. Return
MWA
Merkkuri Wealth Advisors Hicksville, New York $161M AUM 19.9% 1-Year Est. Return
BWM
Bosman Wealth Management Redlands, California $161M AUM 115.22% 1-Year Est. Return

Summer Road's Q2 2020 Portfolio in Review

As of Q2 2020, Summer Road held 2 positions worth $46.8M, up 79% from $26.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Summer Road deployed $2.31M of net new capital in Q2 2020, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the most notable exit was Correvio Pharma Corp. Ordinary Shares (Canada), an estimated $97K sold.

  • Summer Road added most to Ocular Therapeutix in Q2 2020, an estimated $2.41M increase.
  • Summer Road fully exited Correvio Pharma Corp. Ordinary Shares (Canada) in Q2 2020, selling an estimated $97K.
  • Summer Road's ten largest holdings make up 100% of its $46.8M portfolio in Q2 2020.
  • Summer Road opened 0 new positions and closed 1 in Q2 2020.
  • Summer Road's portfolio value rose 79% quarter-over-quarter to $46.8M.

Based on Summer Road's 13F filing for Q2 2020, filed 14 Aug 2020.